Cartesian Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.84

+0.12 (+1.38%)

As of Aug 15, 2:11 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +360.0% upside

Low Target $22.44

Average Target $40.66

High Target $45.57

Current Price $8.84

Current
$8.84

Target
$40.66

$22.44 $40.66 avg $45.57

Scenario Analysis

Bear Case

$22.44

153.8%

Low target

Base Case

$40.66

+360.0%

Avg target

Bull Case

$45.57

+415.5%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$12.25

-27.8% from high

52-Week Low

$5.60

+57.9% from low

Target vs 52W High

$40.66

+231.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%